Author: Xiaolin Yuan; Wanrong Yi; Baoyi Liu; Simiao Tian; Fang Cao; Ruoyu Wang; Baiwen Qi; Faqiang Lu; Meiyun Fang; Fuyang Pei; Ming Chen; Lichuan Zhang; Yong Zhang; Xiuzhi Zhang; Zhenyu Pan; Dewei Zhao; Aixi Yu
Title: Pulmonary radiological change of COVID-19 patients with 99mTc-MDP treatment Document date: 2020_4_14
ID: gzao2fo6_9
Snippet: is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.04.07.20054767 doi: medRxiv preprint treated for 7 days. The primary end point was the CT-based radiological pulmonary changes from baseline to 7 days. The secondary end points were disease progression from mild to severe on the day 7, as well as radiological pulmonary changes during 7 days to 14 days after treatment......
Document: is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.04.07.20054767 doi: medRxiv preprint treated for 7 days. The primary end point was the CT-based radiological pulmonary changes from baseline to 7 days. The secondary end points were disease progression from mild to severe on the day 7, as well as radiological pulmonary changes during 7 days to 14 days after treatment.
Search related documents:
Co phrase search for related documents- disease progression and mild disease progression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- disease progression and primary end point: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- disease progression and pulmonary change: 1
- disease progression and secondary end: 1, 2, 3, 4, 5
- disease progression and secondary end point: 1, 2
- end point and mild disease progression: 1
- end point and primary end point: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- end point and secondary end: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- end point and secondary end point: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- mild disease progression and primary end point: 1
- primary end point and secondary end: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- primary end point and secondary end point: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
Co phrase search for related documents, hyperlinks ordered by date